Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1986 Sep;145(3):343–349.

Drug-Induced Pulmonary Vascular Disease—Mechanisms and Clinical Patterns

Kusum Kumar 1, William E Holden 1
PMCID: PMC1306919  PMID: 3532567

Abstract

An extensive vascular surface area places the lungs at risk for damage by blood-borne drugs. Drug-induced pulmonary vascular disease may present clinically as acute pulmonary edema, pulmonary edema followed by diffuse interstitial lung disease, pulmonary vascular occlusion, pulmonary hypertension or hemorrhage. It is important to recognize these reactions as drug-related because many are reversible with discontinuation of the drug and supportive therapy. Failure to recognize drug-induced pulmonary vascular disease can lead to significant morbidity and, in some cases, death.

Full text

PDF
343

Images in this article

346Figure 1.
on p.346
347Figure 2.
on p.347
347Figure 2.
on p.347
347Figure 3.
on p.347

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson I. Y. Drug-induced pulmonary fibrosis. Environ Health Perspect. 1984 Apr;55:25–36. doi: 10.1289/ehp.845525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson J. L., Wagner J. M., Datz F. L., Christian P. E., Bray B. E., Taylor A. T. Comparative effects of diltiazem, propranolol, and placebo on exercise performance using radionuclide ventriculography in patients with symptomatic coronary artery disease: results of a double-blind, randomized, crossover study. Am Heart J. 1984 Apr;107(4):698–706. doi: 10.1016/0002-8703(84)90317-x. [DOI] [PubMed] [Google Scholar]
  3. BRON K. M., BAUM S., ABRAMS H. L. Oil embolism in lymphangiography. Incidence, manifestations, and mechanism. Radiology. 1963 Feb;80:194–202. doi: 10.1148/80.2.194. [DOI] [PubMed] [Google Scholar]
  4. Bass B. H. Hydralazine lung. Thorax. 1981 Sep;36(9):695–696. doi: 10.1136/thx.36.9.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Belin R. P., Shea M. A., Stone N. H., Griffen W. O. Iodoliposputosis following lymphangiography. Report of a case. Dis Chest. 1965 Nov;48(5):543–544. doi: 10.1378/chest.48.5.543. [DOI] [PubMed] [Google Scholar]
  6. Berend N. Protective effect of hypoxia on bleomycin lung toxicity in the rat. Am Rev Respir Dis. 1984 Aug;130(2):307–308. doi: 10.1164/arrd.1984.130.2.307. [DOI] [PubMed] [Google Scholar]
  7. Bowers R. E., Brigham K. L., Owen P. J. Salicylate pulmonary edema: the mechanism in sheep and review of the clinical literature. Am Rev Respir Dis. 1977 Feb;115(2):261–268. doi: 10.1164/arrd.1977.115.2.261. [DOI] [PubMed] [Google Scholar]
  8. Boyd M. R., Catignani G. L., Sasame H. A., Mitchell J. R., Stiko A. W. Acute pulmonary injury in rats by nitrofurantoin and modification by vitamin E, dietary fat, and oxygen. Am Rev Respir Dis. 1979 Jul;120(1):93–99. doi: 10.1164/arrd.1979.120.1.93. [DOI] [PubMed] [Google Scholar]
  9. Brandstetter R. D., Tamarin F. M., Rangraj M. S., Ruiz M., Giampietro J. Moxalactam disodium-induced pulmonary hemorrhage. Chest. 1984 Oct;86(4):644–645. doi: 10.1378/chest.86.4.644. [DOI] [PubMed] [Google Scholar]
  10. Bus J. S., Gibson J. E. Paraquat: model for oxidant-initiated toxicity. Environ Health Perspect. 1984 Apr;55:37–46. doi: 10.1289/ehp.845537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Capan L. M., Lardizabal S., Sinha K., Ashok U., Berenstein A., Turndorf H. Acute pulmonary embolism during therapeutic arterial embolization with silicone fluids. Anesthesiology. 1983 Jun;58(6):569–571. doi: 10.1097/00000542-198306000-00018. [DOI] [PubMed] [Google Scholar]
  12. Carlson R. W., Schaeffer R. C., Jr, Michaels S. G., Weil M. H. Pulmonary edema fluid. Spectrum of features in 37 patients. Circulation. 1979 Nov;60(5):1161–1169. doi: 10.1161/01.cir.60.5.1161. [DOI] [PubMed] [Google Scholar]
  13. Chlebowski R. T. Adriamycin (doxorubicin) cardiotoxicity: a review. West J Med. 1979 Nov;131(5):364–368. [PMC free article] [PubMed] [Google Scholar]
  14. Crandall E. D., Staub N. C., Goldberg H. S., Effros R. M. Recent developments in pulmonary edema. Ann Intern Med. 1983 Dec;99(6):808–822. doi: 10.7326/0003-4819-99-6-808. [DOI] [PubMed] [Google Scholar]
  15. Crouch E., Churg A. Progressive massive fibrosis of the lung secondary to intravenous injection of talc. A pathologic and mineralogic analysis. Am J Clin Pathol. 1983 Oct;80(4):520–526. doi: 10.1093/ajcp/80.4.520. [DOI] [PubMed] [Google Scholar]
  16. Danielli J. F. Capillary permeability and oedema in the perfused frog. J Physiol. 1940 Mar 14;98(1):109–129. doi: 10.1113/jphysiol.1940.sp003837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Davidson J. W., Kaufman S. D. Pulmonary complications of lymphography. N Engl J Med. 1971 Jul 22;285(4):237–238. doi: 10.1056/NEJM197107222850421. [DOI] [PubMed] [Google Scholar]
  18. Derks C. M., Jacobovitz-Derks D. Embolic pneumopathy induced by oleic acid. A systematic morphologic study. Am J Pathol. 1977 Apr;87(1):143–158. [PMC free article] [PubMed] [Google Scholar]
  19. FRAIMOW W., WALLACE S., LEWIS P., GREENING R. R., CATHCART R. T. CHANGES IN PULMONARY FUNCTION DUE TO LYMPHANGIOGRAPHY. Radiology. 1965 Aug;85:231–241. doi: 10.1148/85.2.231. [DOI] [PubMed] [Google Scholar]
  20. Fairman R. P., Glauser F. L., Falls R. Increases in lung lymph and albumin clearance with ethchlorvynol. J Appl Physiol Respir Environ Exerc Physiol. 1981 Jun;50(6):1151–1155. doi: 10.1152/jappl.1981.50.6.1151. [DOI] [PubMed] [Google Scholar]
  21. Finley J., Katz M., Rojas-Perez M., Roberts J. M., Creasy R. K., Schiller N. B. Cardiovascular consequences of beta-agonist tocolysis: an echocardiographic study. Obstet Gynecol. 1984 Dec;64(6):787–791. [PubMed] [Google Scholar]
  22. Finley T. N., Aronow A., Cosentino A. M., Golde D. W. Occult pulmonary hemorrhage in anticoagulated patients. Am Rev Respir Dis. 1975 Jul;112(1):23–29. doi: 10.1164/arrd.1975.112.1.23. [DOI] [PubMed] [Google Scholar]
  23. Frand U. I., Shim C. S., Williams M. H., Jr Heroin-induced pulmonary edema. Sequential studies of pulmonary function. Ann Intern Med. 1972 Jul;77(1):29–35. doi: 10.7326/0003-4819-77-1-29. [DOI] [PubMed] [Google Scholar]
  24. Gil J., McNiff J. M. Early tissue damage in ethchlorvynol-induced alveolar edema in rabbit lung. Am Rev Respir Dis. 1982 Oct;126(4):701–707. doi: 10.1164/arrd.1982.126.4.701. [DOI] [PubMed] [Google Scholar]
  25. Gillmer D. J., Kark P. Pulmonary oedema precipitated by nifedipine. Br Med J. 1980 Jun 14;280(6229):1420–1421. doi: 10.1136/bmj.280.6229.1420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Glauser F. L., Fairman R. P., Millen J. E., Falls R. K. Indomethacin blunts ethchlorvynol-induced pulmonary hypertension but not pulmonary edema. J Appl Physiol Respir Environ Exerc Physiol. 1982 Sep;53(3):563–566. doi: 10.1152/jappl.1982.53.3.563. [DOI] [PubMed] [Google Scholar]
  27. Glauser F. L., Smith W. R., Caldwell A., Hoshiko M., Dolan G. S., Baer H., Olsher N. Ethchlorvynol (Placidyl)-induced pulmonary edema. Ann Intern Med. 1976 Jan;84(1):46–48. doi: 10.7326/0003-4819-84-1-46. [DOI] [PubMed] [Google Scholar]
  28. Goff A. M., Gaensler E. A. Respiratory distress syndrome following lymphangiography. Respiration. 1971;28(1):89–97. doi: 10.1159/000192805. [DOI] [PubMed] [Google Scholar]
  29. Goldberg S. K., Lipschutz J. B., Ricketts R. M., Fein A. M. Procainamide-induced lupus lung disease characterized by neutrophil alveolitis. Am J Med. 1984 Jan;76(1):146–150. doi: 10.1016/0002-9343(84)90763-0. [DOI] [PubMed] [Google Scholar]
  30. Gurtner H. P. Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite depressant drug aminorex: post or propter? Bull Eur Physiopathol Respir. 1979 Sep-Oct;15(5):897–923. [PubMed] [Google Scholar]
  31. Hawker F. Pulmonary oedema associated with beta 2-sympathomimetic treatment of premature labour. Anaesth Intensive Care. 1984 May;12(2):143–151. doi: 10.1177/0310057X8401200212. [DOI] [PubMed] [Google Scholar]
  32. Heffner J. E., Sahn S. A. Salicylate-induced pulmonary edema. Clinical features and prognosis. Ann Intern Med. 1981 Oct;95(4):405–409. doi: 10.7326/0003-4819-95-4-405. [DOI] [PubMed] [Google Scholar]
  33. Heinsimer J. A., Lefkowitz R. J. The beta-adrenergic receptor in heart failure. Hosp Pract (Off Ed) 1983 Nov;18(11):103-9, 113-7, 121-5. doi: 10.1080/21548331.1983.11702685. [DOI] [PubMed] [Google Scholar]
  34. Hennig B., Shasby D. M., Fulton A. B., Spector A. A. Exposure to free fatty acid increases the transfer of albumin across cultured endothelial monolayers. Arteriosclerosis. 1984 Sep-Oct;4(5):489–497. doi: 10.1161/01.atv.4.5.489. [DOI] [PubMed] [Google Scholar]
  35. Holmberg L., Boman G., Böttiger L. E., Eriksson B., Spross R., Wessling A. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med. 1980 Nov;69(5):733–738. doi: 10.1016/0002-9343(80)90443-x. [DOI] [PubMed] [Google Scholar]
  36. Hosenpud J. D., Morton M. J., O'Grady J. P. Cardiac stimulation during ritodrine hydrochloride tocolytic therapy. Obstet Gynecol. 1983 Jul;62(1):52–58. [PubMed] [Google Scholar]
  37. Huchon G. J., Russell J. A., Barritault L. G., Lipavsky A., Murray J. F. Chronic air-flow limitation does not increase respiratory epithelial permeability assessed by aerosolized solute, but smoking does. Am Rev Respir Dis. 1984 Sep;130(3):457–460. doi: 10.1164/arrd.1984.130.3.457. [DOI] [PubMed] [Google Scholar]
  38. Joselson R., Warnock M. Pulmonary veno-occlusive disease after chemotherapy. Hum Pathol. 1983 Jan;14(1):88–91. doi: 10.1016/s0046-8177(83)80052-5. [DOI] [PubMed] [Google Scholar]
  39. Katz S., Aberman A., Frand U. I., Stein I. M., Fulop M. Heroin pulmonary edema. Evidence for increased pulmonary capillary permeability. Am Rev Respir Dis. 1972 Sep;106(3):472–474. doi: 10.1164/arrd.1972.106.3.472. [DOI] [PubMed] [Google Scholar]
  40. Kay J. M., Harris P., Heath D. Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds. Thorax. 1967 Mar;22(2):176–179. doi: 10.1136/thx.22.2.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kay J. M., Smith P., Heath D. Electron microscopy of Crotalaria pulmonary hypertension. Thorax. 1969 Sep;24(5):511–526. doi: 10.1136/thx.24.5.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Kleiger R. E., Boxer M., Ingham R. E., Harrison D. C. Pulmonary hypertension in patients using oral contraceptives. A report of six cases. Chest. 1976 Feb;69(2):143–147. doi: 10.1378/chest.69.2.143. [DOI] [PubMed] [Google Scholar]
  43. Kudenchuk P. J., Pierson D. J., Greene H. L., Graham E. L., Sears G. K., Trobaugh G. B. Prospective evaluation of amiodarone pulmonary toxicity. Chest. 1984 Oct;86(4):541–548. doi: 10.1378/chest.86.4.541. [DOI] [PubMed] [Google Scholar]
  44. Leatherman J. W., Davies S. F., Hoidal J. R. Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage in immune and idiopathic disorders. Medicine (Baltimore) 1984 Nov;63(6):343–361. [PubMed] [Google Scholar]
  45. Mabie W. C., Pernoll M. L., Witty J. B., Biswas M. K. Pulmonary edema induced by betamimetic drugs. South Med J. 1983 Nov;76(11):1354–1360. doi: 10.1097/00007611-198311000-00007. [DOI] [PubMed] [Google Scholar]
  46. Marchlinski F. E., Gansler T. S., Waxman H. L., Josephson M. E. Amiodarone pulmonary toxicity. Ann Intern Med. 1982 Dec;97(6):839–845. doi: 10.7326/0003-4819-97-6-839. [DOI] [PubMed] [Google Scholar]
  47. Martin W. J., 2nd, Powis G. W., Kachel D. L. Nitrofurantoin-stimulated oxidant production in pulmonary endothelial cells. J Lab Clin Med. 1985 Jan;105(1):23–29. [PubMed] [Google Scholar]
  48. Martin W. J., Howard D. M. Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug. Am J Pathol. 1985 Sep;120(3):344–350. [PMC free article] [PubMed] [Google Scholar]
  49. Masi A. T. Editorial: Pulmonary hypertension and oral contraceptive usage. Chest. 1976 Apr;69(4):451–453. doi: 10.1378/chest.69.4.451b. [DOI] [PubMed] [Google Scholar]
  50. McKeen C. R., Brigham K. L., Bowers R. E., Harris T. R. Pulmonary vascular effects of fat emulsion infusion in unanesthetized sheep. Prevention by indomethacin. J Clin Invest. 1978 May;61(5):1291–1297. doi: 10.1172/JCI109046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Monroe P., Morrow C. F., Jr, Millen J. E., Fairman R. P., Glauser F. L. Acute respiratory failure after sodium morrhuate esophageal sclerotherapy. Gastroenterology. 1983 Sep;85(3):693–699. [PubMed] [Google Scholar]
  52. Mountain R., Ferguson S., Fowler A., Hyers T. Noncardiac pulmonary edema following administration of parenteral paraldehyde. Chest. 1982 Sep;82(3):371–372. doi: 10.1378/chest.82.3.371. [DOI] [PubMed] [Google Scholar]
  53. Måre K., Violante M. Pulmonary edema induced by contrast medium. A comparative investigation in the rat following high intravenous doses of one ionic (diatrizoate) and non-ionic (metrizamide) contrast medium. Acta Radiol Diagn (Stockh) 1983;24(6):481–485. doi: 10.1177/028418518302400609. [DOI] [PubMed] [Google Scholar]
  54. Nestico P. F., Hakki A. H., Iskandrian A. S. Effects of cardiac medications on ventricular performance: emphasis on evaluation with radionuclide angiography. Am Heart J. 1985 May;109(5 Pt 1):1070–1084. doi: 10.1016/0002-8703(85)90251-0. [DOI] [PubMed] [Google Scholar]
  55. Nyman U., Almén T. Effects of contrast media on aortic endothelium. Experiments in the rat with non-ionic monomeric and monoacidic dimeric contrast media. Acta Radiol Suppl. 1980;362:65–71. [PubMed] [Google Scholar]
  56. Oxenhandler R. W. Pulmonary vasculitis in a patient taking nitrofurantoin. Case report. Mo Med. 1977 Jan;74(1):25–28. [PubMed] [Google Scholar]
  57. Pannier R. Drug induced lung disease. Eur J Respir Dis Suppl. 1983;126:151–156. [PubMed] [Google Scholar]
  58. Persson C. G., Erjefält I. Terbutaline and adrenaline inhibit leakage of fluid and protein in guinea-pig lung. Eur J Pharmacol. 1979 Apr 15;55(2):199–201. doi: 10.1016/0014-2999(79)90392-3. [DOI] [PubMed] [Google Scholar]
  59. Peterson B. T., Ross J. C., Brigham K. L. Effect of naloxone on the pulmonary vascular responses to graded levels of intracranial hypertension in anesthetized sheep. Am Rev Respir Dis. 1983 Dec;128(6):1024–1029. doi: 10.1164/arrd.1983.128.6.1024. [DOI] [PubMed] [Google Scholar]
  60. Phan S. H., Fantone J. C. Inhibition of bleomycin-induced pulmonary fibrosis by lipopolysaccharide. Lab Invest. 1984 May;50(5):587–591. [PubMed] [Google Scholar]
  61. Pogson G. W., Sharma J., Crouch T. T. Pulmonary edema with low-dose propranolol in pheochromocytoma. South Med J. 1980 Jun;73(6):795–796. doi: 10.1097/00007611-198006000-00036. [DOI] [PubMed] [Google Scholar]
  62. Raininko R. Endothelial permeability increase produced by angiographic contrast media. Rofo. 1979 Oct;131(4):433–438. doi: 10.1055/s-0029-1231465. [DOI] [PubMed] [Google Scholar]
  63. Rinaldo J., Goldstein R. H., Snider G. L. Modification of oxygen toxicity after lung injury by bleomycin in hamsters. Am Rev Respir Dis. 1982 Dec;126(6):1030–1033. doi: 10.1164/arrd.1982.126.6.1030. [DOI] [PubMed] [Google Scholar]
  64. Rosenow E. C., 3rd The spectrum of drug-induced pulmonary disease. Ann Intern Med. 1972 Dec;77(6):977–991. doi: 10.7326/0003-4819-77-6-977. [DOI] [PubMed] [Google Scholar]
  65. Ryan U. S., Schultz D. R., Ruan J. W. Fc and C3b receptors on pulmonary endothelial cells: induction by injury. Science. 1981 Oct 30;214(4520):557–558. doi: 10.1126/science.6270789. [DOI] [PubMed] [Google Scholar]
  66. Sartwell P. E., Masi A. T., Arthes F. G., Greene G. R., Smith H. E. Thromboembolism and oral contraceptives: an epidemiologic case-control study. Am J Epidemiol. 1969 Nov;90(5):365–380. doi: 10.1093/oxfordjournals.aje.a121082. [DOI] [PubMed] [Google Scholar]
  67. Schneeberger E. E. Proteins and vesicular transport in capillary endothelium. Fed Proc. 1983 May 15;42(8):2419–2424. [PubMed] [Google Scholar]
  68. Shasby D. M., Lind S. E., Shasby S. S., Goldsmith J. C., Hunninghake G. W. Reversible oxidant-induced increases in albumin transfer across cultured endothelium: alterations in cell shape and calcium homeostasis. Blood. 1985 Mar;65(3):605–614. [PubMed] [Google Scholar]
  69. Silvestri R. C., Huseby J. S., Rughani I., Thorning D., Culver B. H. Respiratory distress syndrome from lymphangiography contrast medium. Am Rev Respir Dis. 1980 Oct;122(4):543–549. doi: 10.1164/arrd.1980.122.4.543. [DOI] [PubMed] [Google Scholar]
  70. Simani A. S., Inoue S., Hogg J. C. Penetration of the respiratory epithelium of guinea pigs following exposure to cigarette smoke. Lab Invest. 1974 Jul;31(1):75–81. [PubMed] [Google Scholar]
  71. Sloand E. M., Thompson B. T. Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. Arch Intern Med. 1984 Jan;144(1):173–174. [PubMed] [Google Scholar]
  72. Slutsky R. A., Brown J. J., Strich G. Extravascular lung water: effects of using ionic contrast media at varying levels of left atrial pressure and during myocardial ischemia. Radiology. 1984 Sep;152(3):575–578. doi: 10.1148/radiology.152.3.575. [DOI] [PubMed] [Google Scholar]
  73. Steinberg A. D., Karliner J. S. The clinical spectrum of heroin pulmonary edema. Arch Intern Med. 1968 Aug;122(2):122–127. [PubMed] [Google Scholar]
  74. Stephenson A. H., Sprague R. S., Dahms T. E., Lonigro A. J. Unilateral acute lung injury induced by ethchlorvynol in anesthetized dogs. J Appl Physiol Respir Environ Exerc Physiol. 1984 May;56(5):1252–1259. doi: 10.1152/jappl.1984.56.5.1252. [DOI] [PubMed] [Google Scholar]
  75. Sternlieb I., Bennett B., Scheinberg I. H. D-penicillamine induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med. 1975 May;82(5):673–676. doi: 10.7326/0003-4819-82-5-673. [DOI] [PubMed] [Google Scholar]
  76. Stroncek D. F., Hutton S. W., Silvis S. E., Vercellotti G. M., Jacob H. S., Hammerschmidt D. E. Sodium morrhuate stimulates granulocytes and damages erythrocytes and endothelial cells: probable mechanism of an adverse reaction during sclerotherapy. J Lab Clin Med. 1985 Nov;106(5):498–504. [PubMed] [Google Scholar]
  77. Sundström G., Zauner C. W., Arborelius M., Jr Decrease in pulmonary diffusing capacity during lipid infusion in healthy men. J Appl Physiol. 1973 Jun;34(6):816–820. doi: 10.1152/jappl.1973.34.6.816. [DOI] [PubMed] [Google Scholar]
  78. Toledo C. H., Ross W. E., Hood C. I., Block E. R. Potentiation of bleomycin toxicity by oxygen. Cancer Treat Rep. 1982 Feb;66(2):359–362. [PubMed] [Google Scholar]
  79. Tryka A. F., Skornik W. A., Godleski J. J., Brain J. D. Potentiation of bleomycin-induced lung injury by exposure to 70% oxygen. Morphologic assessment. Am Rev Respir Dis. 1982 Dec;126(6):1074–1079. doi: 10.1164/arrd.1982.126.6.1074. [DOI] [PubMed] [Google Scholar]
  80. Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J. 1968 Apr 27;2(5599):199–205. doi: 10.1136/bmj.2.5599.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Wagner J. M., Morton M. J., Johnson K. A., O'Grady J. P., Speroff L. Terbutaline and maternal cardiac function. JAMA. 1981 Dec 11;246(23):2697–2701. [PubMed] [Google Scholar]
  82. Weg J. G., Harkleroad L. E. Aberrations in pulmonary function due to lymphangiography. Dis Chest. 1968 May;53(5):534–540. doi: 10.1378/chest.53.5.534. [DOI] [PubMed] [Google Scholar]
  83. Wheeler A. S., Patel K. F., Spain J. Pulmonary edema during beta-2-tocolytic therapy. Anesth Analg. 1981 Sep;60(9):695–696. [PubMed] [Google Scholar]
  84. Wiertz L. M., Gagnon J. H., Anthonisen N. R. Intrapulmonary hemorrhage with anemia after lymphography. N Engl J Med. 1971 Dec 9;285(24):1364–1365. doi: 10.1056/NEJM197112092852409. [DOI] [PubMed] [Google Scholar]
  85. Wysolmerski R., Lagunoff D., Dahms T. Ethchlorvynol-induced pulmonary edema in rats. An ultrastructural study. Am J Pathol. 1984 Jun;115(3):447–457. [PMC free article] [PubMed] [Google Scholar]
  86. Young R. C., Ozols R. F., Myers C. E. The anthracycline antineoplastic drugs. N Engl J Med. 1981 Jul 16;305(3):139–153. doi: 10.1056/NEJM198107163050305. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES